Total skin electron beam therapy
Showing 26 - 50 of >10,000
Esophagus Cancer, Esophageal Cancer, Cancer of the Esophagus Trial in Saint Louis (Proton beam therapy, Patient-Reported Outcome
Active, not recruiting
- Esophagus Cancer
- +2 more
- Proton beam therapy
- Patient-Reported Outcome Measures
-
Saint Louis, MissouriWashington University School of Medicine
Aug 10, 2022
Non Small Cell Lung Cancer Trial in Scottsdale, Rochester (Proton Beam Therapy, Carboplatin, Paclitaxel)
Recruiting
- Non Small Cell Lung Cancer
- Proton Beam Therapy
- +2 more
-
Scottsdale, Arizona
- +1 more
Nov 9, 2022
Pelvic Radiation Therapy in Childhood Cancer Survivors
Not yet recruiting
- Cancer
- Childhood Cancer
- Uroflow testing
- +4 more
- (no location specified)
Apr 5, 2023
Clinical Stage I Esophageal Adenocarcinoma AJCC v8, Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8, Clinical Stage
Recruiting
- Clinical Stage I Esophageal Adenocarcinoma AJCC v8
- +66 more
- Carboplatin
- +10 more
-
Phoenix, Arizona
- +76 more
Jan 11, 2023
Head Neck Cancers - Nasopharyngeal Trial in Giza (photon therapy face mask)
Completed
- Head and Neck Cancers - Nasopharyngeal
- photon therapy face mask
-
Giza, Egyptfaculty of physical therapy , Cairo university
May 9, 2023
Paranasal Sinus Cancer, Nasal Cavity Tumor, Nasal Cavity Adenocarcinoma Trial in United States (drug, radiation, procedure)
Completed
- Paranasal Sinus Cancer
- +2 more
- Cisplatin
- +3 more
-
Basking Ridge, New Jersey
- +4 more
Jan 17, 2023
Recurrent Endometrial Carcinoma, Unresectable Endometrial Carcinoma Trial in Miami (Lenvatinib, Pembrolizumab, Hypofractionated
Not yet recruiting
- Recurrent Endometrial Carcinoma
- Unresectable Endometrial Carcinoma
- Lenvatinib
- +2 more
-
Miami, FloridaUniversity of Miami
Jan 10, 2023
Radiation-Induced Dermatitis Trial in Chengdu (Tetrahydrobiopterin)
Not yet recruiting
- Radiation-Induced Dermatitis
-
Chengdu, Sichuan, Chinaest China Second Hospital of Sichuan University
Feb 25, 2022
Refractory Non-Hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma Trial in Duarte, Hackensack, Houston (SIRPant-M, External-beam
Not yet recruiting
- Refractory Non-Hodgkin Lymphoma
- Relapsed Non-Hodgkin Lymphoma
- SIRPant-M
- External-beam radiotherapy (XRT)
-
Duarte, California
- +2 more
Jul 21, 2023
Breast Cancer Trial (Proton Therapy)
Not yet recruiting
- Breast Cancer
- Proton Therapy
- (no location specified)
May 3, 2023
Retroperitoneal Sarcoma Trial in Washington, Baltimore (Hypofractionated Proton Beam Therapy)
Not yet recruiting
- Retroperitoneal Sarcoma
- Hypofractionated Proton Beam Therapy
-
Washington, District of Columbia
- +1 more
Jul 15, 2022
NSCLC Trial in Cleveland (Durvalumab, Proton beam therapy RT)
Active, not recruiting
- Non-Small Cell Lung Cancer
- Durvalumab
- Proton beam therapy RT
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Jul 5, 2022
Ann Arbor Stage I B-Cell Non-Hodgkin Lymphoma, Ann Arbor Stage I Grade 1 Follicular Lymphoma, Ann Arbor Stage I Grade 2
Active, not recruiting
- Ann Arbor Stage I B-Cell Non-Hodgkin Lymphoma
- +22 more
- External Beam Radiation Therapy
- Orbital Radiation
-
Houston, TexasM D Anderson Cancer Center
Dec 9, 2022
Rectal Cancer Trial in Stockholm (Radiation therapy)
Recruiting
- Rectal Cancer
- Radiation therapy
-
Stockholm, Solna, SwedenKarolinska University Hospital, Theme Cancer, Dept of Pelvic can
Aug 15, 2022
Atopic Dermatitis Trial in Worldwide (Abrocitinib 200 mg, Dupilumab 300 mg)
Completed
- Atopic Dermatitis
- Abrocitinib 200 mg
- Dupilumab 300 mg
-
Birmingham, Alabama
- +150 more
Jun 9, 2022
Parent Mental Health, Parenting, Child Mental Health Trial in Vancouver (Building Emotion Awareness and Mental Health (BEAM))
Not yet recruiting
- Parent Mental Health
- +3 more
- Building Emotion Awareness and Mental Health (BEAM)
-
Vancouver, British Columbia, CanadaUniversity of British Columbia
Sep 13, 2023
Head Neck Cancer, Thoracic Cancer, Abdominal Cancer Trial (HyperSight imaging)
Not yet recruiting
- Head and Neck Cancer
- +3 more
- HyperSight imaging
- (no location specified)
Jul 26, 2023
Esophageal Cancer Trial in Houston (Proton Beam Therapy (PBT), Intensity Modulated Radiation Therapy (IMRT), Questionnaires)
Active, not recruiting
- Esophageal Cancer
- Proton Beam Therapy (PBT)
- +2 more
-
Houston, TexasMD Anderson Cancer Center
Oct 11, 2022
Recurrent Rectal Cancer Trial in Saint Louis (Hypofractionated Pencil-Beam Scanning Intensity-modulated Proton Therapy, MEVION
Recruiting
- Recurrent Rectal Cancer
- Hypofractionated Pencil-Beam Scanning Intensity-modulated Proton Therapy
- MEVION S250i Hyperscan and Adaptive Aperture Proton Therapy Machine
-
Saint Louis, MissouriWashington University School of Medicine
Dec 8, 2022
Gastric Cancer, GastroEsophageal Cancer Trial in Aurora, Colorado Springs, Highlands Ranch (Pembrolizumab, Olaparib,
Recruiting
- Gastric Cancer
- GastroEsophageal Cancer
- Pembrolizumab
- +2 more
-
Aurora, Colorado
- +2 more
Jan 4, 2023
Stage II NSCLC AJCC v7, Stage IIA Non-Small Cell Lung Carcinoma AJCC v7, Stage IIB Non-Small Cell Lung Carcinoma AJCC v7 Trial
Recruiting
- Stage II Non-Small Cell Lung Cancer AJCC v7
- +5 more
- Carboplatin
- +9 more
-
Jacksonville, Florida
- +29 more
Dec 15, 2022
Multiple Myeloma Trial in Seattle (Allopurinol, Carmustine, Etoposide)
Recruiting
- Multiple Myeloma
- Allopurinol
- +4 more
-
Seattle, WashingtonSwedish Cancer Institute
Jun 21, 2022
Bone Metastases Trial in Palo Alto (MR- High intensity focused ultrasound, External beam radiotherapy)
Not yet recruiting
- Bone Metastases
- MR- High intensity focused ultrasound
- External beam radiotherapy
-
Palo Alto, CaliforniaStanford University
Jun 10, 2022
Breast Cancer Trial in Worthington, Fargo, Sioux Falls (IMRT/VMAT-Based Accelerated Partial Breast Irradiation)
Recruiting
- Breast Cancer
- IMRT/VMAT-Based Accelerated Partial Breast Irradiation
-
Worthington, Minnesota
- +2 more
Nov 11, 2022
Resectable Lung Non-Small Cell Carcinoma Trial in Atlanta (procedure, radiation, other)
Not yet recruiting
- Resectable Lung Non-Small Cell Carcinoma
- Biospecimen Collection
- +2 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Aug 22, 2023